Patent · US Active

Compositions and methods for treatment of bone associated diseases

US11098091B2 · kind B2 · utility

1Cited by

5References

7Claims

0Family size

Assignees

The National Institute for Biotechnology in the Negev Ltd. · IL
B. G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY · IL

Inventors

Niv Papo · Palo Alto, US
Noam Levaot · Rahat, IL
Yuval Zur · Netanya, IL
Lior Rosenfeld · Holon, IL

Key dates

Filing date	Aug 17, 2017
Grant date	Aug 24, 2021
Priority date	—
Expiry date	Aug 17, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Mutant M-CSF protein, comprising αvβ3 integrin binding motif and pharmaceutical compositions comprising same, are provided. Further, use of the composition for the treatment and or prevention of diseases associated with increased bone resorption are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.